Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TIAM2

- PMLiVE

NHS programme to give melanoma patients fast-track access to skin cancer vaccine

The phase 2 study will evaluate Scancell's iSCIB1+ in patients with advanced unresectable melanoma

- PMLiVE

ICR researchers uncover genes responsible for tumour progression in prostate cancer

The findings could pave the way for new treatment approaches that improve patient outcomes

regeneron headquarters

Regeneron shares positive phase 3 results for Libtayo in high-risk skin cancer

Approximately 1.8 million cases of cutaneous squamous cell carcinoma are diagnosed in the US every year

- PMLiVE

ICR study reveals how PARP inhibitor resistance develops in prostate cancer patients

The research could pave the way for the development of new drugs that prevent drug resistance

- PMLiVE

ICR researchers identify potential treatment approach for acute myeloid leukaemia

More than 3,100 people are diagnosed with the aggressive blood cancer in the UK every year

- PMLiVE

ICR researchers reveal benefits of personalised radiotherapy for bladder cancer patients

More than 130,000 patients are treated with radiotherapy on the NHS every year

- PMLiVE

ICR researchers identify new drug target for advanced prostate cancer patients

The team estimates that around 10% of patients have high levels of the BCL2 protein

- PMLiVE

Merck shares positive ten-year results for Keytruda in advanced melanoma

More than 100,640 cases of the skin cancer are expected to be diagnosed in the US this year

- PMLiVE

Breast cancer drug found to help slow growth of rare childhood brain tumour

Researchers discovered that targeting the CDK6 protein could make tumour cells vulnerable to treatment

- PMLiVE

UK study reveals previously unknown genetic causes of colorectal cancer

The third most commonly diagnosed cancer globally is responsible for more than 44,000 new cases in the UK every year

- PMLiVE

ICR study on cell competition mechanism could lead to new ways of treating cancer

Female breast, lung, bowel and prostate cancers account for more than four in ten of all cancers worldwide

- PMLiVE

Experts issue call for new ‘toolbox’ to simplify early-phase clinical trial regulation in UK

The article outlines several recommendations to help improve early-phase clinical trials

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links